Ralmitaront (RO6889450)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ralmitaront (RO6889450), covering 2024-08-12 to 2024-08-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms [Phase 2]